PTGS2 and malignant colon neoplasm: Considering our results that show increased inhibitory phosphorylation of GSK3β (pSer9-GSK3β) under IBU treatment (Fig 4B), we suggest that IBU-mediated inhibition of GSK3β influences COX-2 expression in hypoxic colon cancer and head and neck cancer cell lines.